Regeneron Pharmaceuticals, Inc.

Chevy Chase Trust Holdings, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

200,747

Value ($000)

154,951

Weight

0.4%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	154,951	0.4%	200,747	12/31/2025
2025 Q3	11/14/2025	114,226	0.3%	203,152	9/30/2025
2025 Q2	7/29/2025	108,532	0.3%	206,728	6/30/2025
2025 Q1	4/23/2025	140,298	0.4%	221,210	3/31/2025
2024 Q4	1/30/2025	163,670	0.5%	229,767	12/31/2024
2024 Q3	11/14/2024	250,594	0.8%	238,379	9/30/2024
2024 Q2	7/22/2024	254,091	0.8%	241,754	6/30/2024
2024 Q1	5/3/2024	233,288	0.8%	242,380	3/31/2024
2023 Q4	1/24/2024	219,201	0.8%	249,577	12/31/2023
2023 Q3	10/23/2023	206,498	0.8%	250,921	9/30/2023
2023 Q2	7/25/2023	181,598	0.7%	252,732	6/30/2023
2023 Q1	5/17/2023	209,089	0.8%	254,468	3/31/2023
2022 Q4	2/9/2023	186,241	0.8%	258,134	12/31/2022
2022 Q3	11/4/2022	193,122	0.8%	280,344	9/30/2022
2022 Q2	8/10/2022	156,924	0.6%	265,463	6/30/2022
2022 Q1	4/27/2022	174,628	0.6%	250,035	3/31/2022
2021 Q4	1/31/2022	146,432	0.5%	231,874	12/31/2021
2021 Q3	10/20/2021	133,899	0.5%	221,256	9/30/2021
2021 Q2	7/20/2021	101,094	0.3%	180,995	6/30/2021
2021 Q1	4/22/2021	80,118	0.3%	169,337	3/31/2021
2020 Q4	2/12/2021	66,250	0.2%	137,130	12/31/2020
2020 Q3	11/6/2020	79,517	0.3%	142,045	9/30/2020
2020 Q2	8/14/2020	83,183	0.3%	133,381	6/30/2020
2020 Q1	5/13/2020	41,700	0.2%	85,403	3/31/2020
2019 Q4	2/12/2020	31,652	0.1%	84,293	12/31/2019
2014 Q2	7/16/2014	16,150	0.1%	57,174	6/30/2014
2014 Q1	4/15/2014	17,305	0.1%	57,630	3/31/2014
2013 Q4	1/23/2014	15,809	0.1%	57,437	12/31/2013